Contipro Biotech introduced its new Delcore autologous delivery system at this year’s in-cosmetics, Paris.
It is a chemically modified hyaluronic acid capable of generating polymeric micelles, into which it is possible to incorporate other cosmetic actives. This means that Delcore can be used to deliver substances which otherwise find it hard to penetrate the stratum corneum. This will increase the efficacy of the substance transported or reduce the concentration of actives while retaining the same effect. Moreover, in in vivo and in vitro tests of Delcore, the unloaded carrier itself has also been shown to have a positive effect on the ageing skin.
